- Home
- INDV vs ATMU Comparison
INDV vs ATMU Comparison
Compare INDV & ATMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | ATMU |
|---|---|---|
| Founded | N/A | 1958 |
| Country | United States | United States |
| Employees | N/A | 4500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.1B |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | INDV | ATMU |
|---|---|---|
| Price | $40.43 | $51.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $58.25 |
| AVG Volume (30 Days) | ★ 1.6M | 797.5K |
| Earning Date | 06-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 8100.00 | 12.61 |
| EPS | ★ 0.69 | 0.59 |
| Revenue | $1,239,000,000.00 | ★ $1,764,300,000.00 |
| Revenue This Year | N/A | $15.00 |
| Revenue Next Year | N/A | $5.13 |
| P/E Ratio | ★ $59.86 | $84.71 |
| Revenue Growth | 4.29 | ★ 5.67 |
| 52 Week Low | $15.00 | $36.74 |
| 52 Week High | $42.81 | $66.50 |
Technical Indicators
Market Signals| Indicator | INDV | ATMU |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 50.94 |
| Support Level | $35.36 | $50.67 |
| Resistance Level | $41.00 | $51.16 |
| Average True Range (ATR) | 1.56 | 1.90 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 55.32 | 41.62 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About ATMU Atmus Filtration Technologies Inc.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.